Search

Your search keyword '"Frkovic, Marijan"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Frkovic, Marijan" Remove constraint Author: "Frkovic, Marijan"
104 results on '"Frkovic, Marijan"'

Search Results

2. Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study

3. Whole exome sequencing in patients with childhood‐onset systemic lupus erythematosus: Results from a Croatian national study.

5. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children.

6. Glutathione S-Transferase Gene Polymorphisms as Predictors of Methotrexate Efficacy in Juvenile Idiopathic Arthritis.

7. Association of Glutathione Transferase M1, T1, P1 and A1 Gene Polymorphism and Susceptibility to IgA Vasculitis.

11. HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis

14. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children

15. Il‐17 inhibitor in patient with juvenile psoriasis and primary immunodeficiency.

17. 2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years

18. The paediatric vasculitis activity score (PVAS) and proteinuria in IgAV nephritis: is there an association with different histologic findings?

19. Association between glutathione S-transferase (GST) M1,T1 and A1 polymorphisms and IgA vasculitis: a pilot study

20. Software Quality Control (SQC) and Oxford classifications predict poor renal outcome better than The International Study of Kidney Disease in Children (ISKDC) and Haas in patients with IgAV nephritis: a multicenter study

21. 445 Determining the effectiveness of systemic immunomodulatory therapy in the treatment of patients with juvenile idiopathic arthritis associated uveitis depending on the chosen outcome measures

22. 446 Single nucleotide polymorphisms of genes HMGB1 and AGER and its association with clinical features of IgA vasculitis

23. 451 Association between gastrointestinal manifestations and the risk of renal disease in children with IgA vasculitis

25. 453 Determining the effectiveness of systemic immunomodulatory therapy in the treatment of patients with juvenile idiopathic arthritis associated uveitis depending on the chosen outcome measures

26. 452 The impact of systemic immunomodulatory therapy on the intraocular inflammation and the need for topical glucocorticoid therapy in patients with juvenile idiopathic arthritis-associated uveitis

28. Application of computerized color telethermography in 225 children and adolescents with Raynaud's phenomenon

29. DiGeorge syndrome; Juvenile idiopathic arthritis; Tumor necrosis factor-alpha inhibitor; Adverse effects

30. Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis

31. P182 Organ damage in croatian cohort of patients with childhood onset systemic lupus erythematosus

33. Persistence and Severity of Cutaneous Manifestations in IgA Vasculitis Is Associated with Development of IgA Vasculitis Nephritis in Children.

34. QUALITY OF LIFE IN JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS: DO WE NEED A NEW ASSESSMENT QUESTIONNAIRE?

35. Periodic fever syndrome with novel TRNT1 variant - possible cause of TRNT1 deficiency or just an incidental finding?

36. Henoch-Schonlein purpura nephritis in Croatian children: a retrospective study in five tertiary care centers

37. Disease activity and organ damage in patient with childhood-onset systemic lupus erythematosus, from childhood to adulthood: a retrospective study over the last 25 years

38. Comparison of Computerized Color Telethermography and Nailfold Capillaroscopy in Diagnostics of Secondary Raynaud’s Phenomenon in Children

39. Simultaneous treatment with TNF inhibitor and IVIG in a patient with primary immunodeficiency and autoimmunity: a treatment conundrum

40. Predicting organ damage in patients with childhood-onset systemic lupus erythematosus: a retrospective study over the last 25 years

41. Childhood-Onset Systemic Lupus Erythematosus over the Last 25 Years: Predicting Organ Damage

43. AB0995 EXPLORING UVEITIS IN EARLY ONSET ANA POSITIVE JIA

44. Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis.

46. Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016

47. Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia

49. Henoch-Schonlein Purpura Nephritis: Different Histological Classifications, but Which One Is Most Strongly Associated to the Outcome of the Disease? Pilot Study of the Paediatric Rheumatology European Society Vasculitis Working Party

50. sj-docx-1-tab-10.1177_1759720X211024828 – Supplemental material for Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis

Catalog

Books, media, physical & digital resources